DK3737470T5 - 3-phenyl-4-hexynsyrederivater som gpr40-agonister - Google Patents

3-phenyl-4-hexynsyrederivater som gpr40-agonister Download PDF

Info

Publication number
DK3737470T5
DK3737470T5 DK19701029.1T DK19701029T DK3737470T5 DK 3737470 T5 DK3737470 T5 DK 3737470T5 DK 19701029 T DK19701029 T DK 19701029T DK 3737470 T5 DK3737470 T5 DK 3737470T5
Authority
DK
Denmark
Prior art keywords
phenyl
acid derivatives
gpr40 agonists
hexynic acid
hexynic
Prior art date
Application number
DK19701029.1T
Other languages
English (en)
Other versions
DK3737470T3 (da
Inventor
Mateusz Mach
Radoslaw Dzida
Damian Smuga
Filip Stelmach
Katarzyna Bazydlo
Krzysztof Dubiel
Maciej Wieczorek
Mikolaj Matloka
Jerzy Pieczykolan
Original Assignee
Celon Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PL424227A external-priority patent/PL233938B1/pl
Application filed by Celon Pharma Sa filed Critical Celon Pharma Sa
Publication of DK3737470T3 publication Critical patent/DK3737470T3/da
Application granted granted Critical
Publication of DK3737470T5 publication Critical patent/DK3737470T5/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/42—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C07C57/60—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK19701029.1T 2018-01-08 2019-01-07 3-phenyl-4-hexynsyrederivater som gpr40-agonister DK3737470T5 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL424227A PL233938B1 (pl) 2018-01-08 2018-01-08 Pochodne kwasu 3-fenylo-4-heksynowego jako agoniści GPR40
PL42562518 2018-05-18
PCT/EP2019/050194 WO2019134984A1 (en) 2018-01-08 2019-01-07 3-phenyl-4-hexynoic acid derivatives as gpr40 agonists

Publications (2)

Publication Number Publication Date
DK3737470T3 DK3737470T3 (da) 2023-03-13
DK3737470T5 true DK3737470T5 (da) 2024-05-27

Family

ID=67144423

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19701029.1T DK3737470T5 (da) 2018-01-08 2019-01-07 3-phenyl-4-hexynsyrederivater som gpr40-agonister

Country Status (14)

Country Link
US (1) US11964938B2 (da)
EP (1) EP3737470B9 (da)
JP (1) JP7289305B2 (da)
KR (1) KR102705659B1 (da)
CN (1) CN111757770B (da)
AU (1) AU2019205093B2 (da)
BR (1) BR112020013694A2 (da)
DK (1) DK3737470T5 (da)
ES (1) ES2939720T3 (da)
FI (1) FI3737470T3 (da)
MX (1) MX2020007283A (da)
PL (1) PL3737470T3 (da)
PT (1) PT3737470T (da)
WO (1) WO2019134984A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022552655A (ja) 2019-10-07 2022-12-19 キャリーオペ,インク. Gpr119アゴニスト
MX2022010548A (es) 2020-02-28 2022-09-23 Kallyope Inc Agonistas de gpr40.
MX2022014505A (es) 2020-05-19 2022-12-13 Kallyope Inc Activadores de la ampk.
CA3183575A1 (en) 2020-06-26 2021-12-30 Iyassu Sebhat Ampk activators
CN121729216A (zh) * 2023-08-11 2026-03-24 生命密码有限公司 促进毛发生长和/或减轻脱发的组合物、药剂和制剂
CN117343066A (zh) * 2023-09-05 2024-01-05 华南师范大学 喹唑啉酮生物碱Brevianamide M衍生物及制备方法与抗炎抗肿瘤应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003277576A1 (en) 2002-11-08 2004-06-07 Takeda Pharmaceutical Company Limited Receptor function controlling agent
US7820837B2 (en) 2003-05-30 2010-10-26 Takeda Pharmaceutical Company Limited Condensed ring compound
US7456218B2 (en) 2003-12-25 2008-11-25 Takeda Pharmaceutical Company Limited 3-(4-benzyloxyphenyl) propanoic acid derivatives
EP1737809B1 (en) * 2004-02-27 2013-09-18 Amgen, Inc Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
WO2005087710A1 (ja) 2004-03-15 2005-09-22 Takeda Pharmaceutical Company Limited アミノフェニルプロパン酸誘導体
US7989457B2 (en) 2004-05-28 2011-08-02 Eli Lilly And Company Glucagon receptor antagonists, preparation and therapeutic uses
US7582803B2 (en) 2005-09-14 2009-09-01 Amgen Inc. Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
AU2007265966B2 (en) 2006-06-27 2012-05-17 Takeda Pharmaceutical Company Limited Fused cyclic compounds
CA2662305C (en) 2006-09-07 2012-04-17 Amgen Inc. Heterocyclic gpr40 modulators
US7750048B2 (en) 2006-11-15 2010-07-06 Janssen Pharmaceutica Nv GPR40 agonists
ES2446419T3 (es) 2007-04-16 2014-03-07 Amgen, Inc Moduladores de GPR40 de ácidos bifenilfenoxi, tiofenil y aminofenilpropanoico sustituidos
US20120172351A1 (en) 2009-06-09 2012-07-05 Nobuyuki Negoro Novel fused cyclic compound and use thereof
AR078522A1 (es) 2009-10-15 2011-11-16 Lilly Co Eli Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis
TW201221505A (en) * 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
IN2013CN01340A (da) 2010-07-23 2015-08-07 Connexios Life Sciences Pvt Ltd
WO2012136221A1 (en) 2011-04-08 2012-10-11 Syddansk Universitet Ortho-fluoro substituted compounds for the treatment of metabolic diseases
AR087451A1 (es) 2011-08-17 2014-03-26 Lilly Co Eli Derivado de 1,2,3,4-tetrahidroquinolina util para tratamiento de diabetes
JP6106179B2 (ja) 2012-02-24 2017-03-29 武田薬品工業株式会社 芳香環化合物
TW201341356A (zh) 2012-02-28 2013-10-16 皮拉馬爾企業有限公司 作為gpr促效劑之苯基烷酸衍生物
US9617263B2 (en) 2014-01-10 2017-04-11 Eli Lilly And Company Phenyl-triazolo-pyridine compounds
EP3207928B1 (en) * 2014-10-17 2021-03-10 Hyundai Pharm Co., Ltd. Composite preparation, containing novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative and another active ingredient, for preventing or treating metabolic diseases

Also Published As

Publication number Publication date
ES2939720T9 (es) 2024-06-04
WO2019134984A1 (en) 2019-07-11
PT3737470T (pt) 2023-03-02
JP7289305B2 (ja) 2023-06-09
US11964938B2 (en) 2024-04-23
ES2939720T3 (es) 2023-04-26
CA3087712A1 (en) 2019-07-11
CN111757770B (zh) 2023-10-03
JP2021509909A (ja) 2021-04-08
EP3737470A1 (en) 2020-11-18
KR102705659B1 (ko) 2024-09-11
US20200399198A1 (en) 2020-12-24
FI3737470T3 (fi) 2023-03-19
BR112020013694A2 (pt) 2020-12-01
KR20200108318A (ko) 2020-09-17
EP3737470B9 (en) 2024-03-13
AU2019205093A1 (en) 2020-07-16
EP3737470B1 (en) 2022-12-14
MX2020007283A (es) 2020-09-10
AU2019205093B2 (en) 2024-03-07
DK3737470T3 (da) 2023-03-13
PL3737470T3 (pl) 2023-05-08
CN111757770A (zh) 2020-10-09

Similar Documents

Publication Publication Date Title
DK3873903T3 (da) Substituerede 6-azabenzimidazolforbindelser som hpk1-hæmmere
DK3768674T3 (da) Aminopyrimidinderivater som ctps1-hæmmere
DK4299135T3 (da) Benzisoxazol-sulfonamid-derivater
IL292161A (en) New methylquinazolinone derivatives
DK3761790T3 (da) Picolinamider som fungicider
DK3737470T3 (da) 3-phenyl-4-hexynsyrederivater som gpr40-agonister
DK3292116T3 (da) 3-aryl-4-amido-bicykliske [4,5,0]hydroxamsyrer som hdac-inhibitorer
DK3313832T3 (da) 3-tetrazolyl-benzen-1,2-disulfonamidderivater som metallo-beta- lactamase-hæmmere
PL3838888T3 (pl) Triestry kwasu cykloheksanotripropionowego
DK3494115T3 (da) N-(phenylsulfonyl)benzamidderivater som bcl-2-hæmmere
DK3580220T3 (da) Aminotriazolpyridiner som kinasehæmmere
DK3277677T3 (da) 1-cyano-pyrrolidinforbindelser som usp30-hæmmere
DK3381918T3 (da) 7-(Thiazol-5-yl)-pyrrolopyrimidinforbindelse som TLR7-agonist
EP4110788A4 (en) Gpr40 agonists
DK3303305T3 (da) 2-(phenyloxy eller phenylthio)pyrimidin-derivater som herbicider
DK3762368T3 (da) Aminopyrazindiolforbindelser som pi3k-y-inhibitorer
DK3271349T3 (da) Benzimidazolederivater som bromodomain-inhibitorer
DK3638680T3 (da) Heteroaromatiske forbindelser som vanininhibitorer
DK3612524T3 (da) 6-pyrimidin-isoindol-derivat som erk1/2-inhibitor
DK3233843T3 (da) Isoxazol-hydraxamsyreforbindelser som LPXC-hæmmere
DK3704118T3 (da) Aminoimidazopyrazin som kinasehæmmere
EP3808783A4 (en) Novel crosslinked alginic acid
DK3013796T3 (da) Biarylderivater som gpr120-agonister
DK3497085T3 (da) Sulfonamider som gpr40- og gpr120-agonister
DK3844161T3 (da) Heteroaromatiske forbindelser som vanininhibitorer.